Queens Infectious Disease

Topics

• Antibiotic Resistance in Bacteria 20
• Tuberculosis Research and Epidemiology 10
• HIV/AIDS drug development and treatment 8
• Antimicrobial Resistance in Staphylococcus 6
• HIV Research and Treatment 6
• Poxvirus research and outbreaks 6
• SARS-CoV-2 and COVID-19 Research 6
• Pneumocystis jirovecii pneumonia detection and treatment 5
• Pneumonia and Respiratory Infections 5
• Antifungal resistance and susceptibility 4
• Clostridium difficile and Clostridium perfringens research 4
• Mycobacterium research and diagnosis 4

Most cited

1. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.

   The New England journal of medicine · 2022 · 255 citations · Sorana Segal-Maurer

2. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025 · 37 citations · Sorana Segal-Maurer

3. Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years.

   The Journal of infectious diseases · 2025 · 31 citations · Sorana Segal-Maurer

4. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.

   The lancet. HIV · 2023 · 66 citations · Sorana Segal-Maurer

5. Positive Correlation Between Candida auris Skin-Colonization Burden and Environmental Contamination at a Ventilator-Capable Skilled Nursing Facility in Chicago.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · 74 citations · Tristan McPherson

6. Notes from the Field: Increase in New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacterales - New York City, 2019-2024.